Skip to main content

Advertisement

Table 2 Demographic characteristics and peripapillary RNFL thickness of the FMF and healthy control groups by colchicine use duration

From: Effect of oral Colchicine on Peripapillary retinal nerve fiber layer thickness in patients with familial Mediterranean fever

Variables Healthy Control Group (n = 32) Untreated FMF Group (n = 25) 6–24 months Treated Group (n = 23) > 24 months Treated Group (n = 18) Kruskal-Wallis test
Age (years) (mean ± SD) 34.72 ± 9.07 32.82 ± 9.85 36.82 ± 11.48 36.16 ± 10.63 p = 0.729
Gender (male/female) 10/22 8/17 7/16 6/12 p = 0.995
Mean RNFL (μm) (mean ± SD) 98.18 ± 1.89 98.17 ± 7.32 100.95 ± 7.76 102.00 ± 9.44 p = 0.344
Superior RNFL (μm) (mean ± SD) 117.04 ± 2.21 115.52 ± 10.28 117.13 ± 10.45 114.00 ± 9.39 p = 0.596
Inferior RNFL (μm) (mean ± SD) 123.72 ± 2.84 125.88 ± 13.77 125.47 ± 9.76 131.33 ± 14.24 p = 0.312
Temporal RNFL (μm) (mean ± SD) 70.45 ± 6.32 72.23 ± 12.16 72.69 ± 11.00 73.05 ± 10.92 p = 0.899
Nasal RNFL (μm) (mean ± SD) 81.27 ± 4.16 80.47 ± 11.53 85.73 ± 13.85 86.61 ± 10.26 p = 0.106
  1. FMF familial Mediterranean fever, RNFL retinal nerve fiber layer, μm micrometer